CVS Health Co. (NYSE:CVS) Shares Sold by Klingman & Associates LLC

Klingman & Associates LLC reduced its position in shares of CVS Health Co. (NYSE:CVS) by 24.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,798 shares of the pharmacy operator’s stock after selling 1,214 shares during the quarter. Klingman & Associates LLC’s holdings in CVS Health were worth $239,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. Livelsberger Financial Advisory purchased a new stake in CVS Health in the 3rd quarter worth $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health during the third quarter worth about $32,000. First Community Trust NA raised its position in shares of CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 302 shares during the last quarter. Kathleen S. Wright Associates Inc. purchased a new position in CVS Health in the 3rd quarter valued at about $33,000. Finally, ORG Partners LLC boosted its holdings in CVS Health by 11,840.0% in the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 592 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Performance

NYSE CVS opened at $55.54 on Friday. The stock has a market cap of $69.87 billion, a PE ratio of 14.10, a P/E/G ratio of 0.94 and a beta of 0.55. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The stock has a fifty day simple moving average of $59.56 and a 200-day simple moving average of $59.19. The company has a current ratio of 0.80, a quick ratio of 0.66 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. During the same period last year, the business earned $2.21 earnings per share. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. Equities analysts anticipate that CVS Health Co. will post 6.18 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.79%. CVS Health’s dividend payout ratio is currently 67.51%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft decreased their target price on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $59.00 to $85.00 in a report on Friday, October 4th. Mizuho dropped their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Evercore ISI raised their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a research note on Tuesday, October 1st. Nine equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $73.00.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.